Key Lessons From the NYC Bar Association’s “How-to” of Successful Motion Practice CLE Panel
Apr 09, 2012
On March 5th, Jane Chuang and Rosanne Felicello co-chaired anevent at the NYC Bar Association on the how-to of successful motion practice. The panelists includedJustice Barbara R. Kapnick, NY Supreme C...
See Full Guide
“Pay-for-delay” Deals – Anticompetitive or Appropriate & Reasonable Settlements?
Oct 25, 2011
This morning the FTC released a staff report that purports to assess the number of pay-for-delay deals entered into by brand and generic drug companies during the fiscal year 2011 (October 1, 2010 to S...
See Full Guide
WillaGirl v. Wella – A worthy trademark dispute?
Sep 29, 2011
What struck me most about todays N.Y. Times article about a start-up cosmetics company focused on pre-teens, WillaGirl LLC, and trademark bully Procter Gamble and its subsidiary, The Wella Corporation...
See Full Guide
The Risky Business of Product Innovation
Aug 18, 2011
If
you develop a drug product, patent it, and bring it to market, are you required
to continue to make it available for sale even if you have developed a better
product to fill the same need? It dep...
See Full Guide
Key Features of the New Whistleblower Provisions of Section 21F of the Securities Exchange Act
Aug 08, 2011
On Friday, August 12, 2011, the United States Securities
Exchange Commissions new Whistleblower Provisions go into effect. Here
are the key points you should know if you manage a public company, work...
See Full Guide
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
The Avvo Rating explained
The Avvo Rating explained